Literature DB >> 18316393

Proliferative diabetic retinopathy in type 2 diabetes is related to coronary artery calcium in the Veterans Affairs Diabetes Trial (VADT).

Peter D Reaven1, Nicholas Emanuele, Thomas Moritz, Ronald Klein, Mathew Davis, Kathy Glander, William Duckworth, Carlos Abraira.   

Abstract

OBJECTIVE: Increasing evidence suggests that macrovascular disease and retinopathy may be more closely linked than previously believed. We determined the relationship between retinopathy and coronary atherosclerosis as measured by computed tomography-detectable coronary artery calcium (CAC). RESEARCH DESIGN AND METHODS: The cross-sectional association between CAC and retinopathy was assessed on a Veteran Affairs Diabetes Trial subsample of 204 subjects with a mean duration of type 2 diabetes of 12.3 +/- 8.3 years.
RESULTS: Retinopathy was correlated with CAC (r = 0.19, P = 0.006). Median CAC increased across retinopathy categories: 197 in those with no retinopathy, 229 in those with microaneurysms only, 364 in those with mild nonproliferative diabetic retinopathy (NPDR), 300 in those with moderate to severe NPDR, and 981 in those with proliferative diabetic retinopathy (PDR). Stepwise multivariable linear regression analysis was performed to find a parsimonious subset of relevant risk factors to include along with PDR in predicting CAC. After adjustment for either this subset of standard factors (P = 0.047) or a more extensive panel of risk factors (P = 0.035), PDR was significantly associated with CAC. Moreover, using logistic regression, individuals with PDR were approximately sixfold more likely to have CAC >400 than those with no PDR, even after adjustment for other CVD risk factors.
CONCLUSIONS: These data indicate an important relationship between retinopathy and extent of CAC and suggest the potential to identify and treat shared risk factors for these common micro- and macrovascular complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316393     DOI: 10.2337/dc07-1926

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  12 in total

Review 1.  Glucose targets for preventing diabetic kidney disease and its progression.

Authors:  Marinella Ruospo; Valeria M Saglimbene; Suetonia C Palmer; Salvatore De Cosmo; Antonio Pacilli; Olga Lamacchia; Mauro Cignarelli; Paola Fioretto; Mariacristina Vecchio; Jonathan C Craig; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2017-06-08

2.  Association between Diabetic Retinopathy and Left Ventricular Dysfunction in Diabetic Patients with Unstable Angina.

Authors:  Ebadollah Heidari; Sanaz Nematzadeh Pakdel; Jahanbakhsh Samadikhah; Rasoul Azarfarin; Kamran Shadvar
Journal:  J Cardiovasc Thorac Res       Date:  2012-10-30

3.  Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Authors:  Julie A Lovshin; Petter Bjornstad; Leif E Lovblom; Johnny-Wei Bai; Yuliya Lytvyn; Geneviève Boulet; Mohammed A Farooqi; Sam Santiago; Andrej Orszag; Daniel Scarr; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Bruce A Perkins; David Z I Cherney
Journal:  Diabetes Care       Date:  2018-10-01       Impact factor: 19.112

Review 4.  Megatrials in type 2 diabetes. From excitement to frustration?

Authors:  S Del Prato
Journal:  Diabetologia       Date:  2009-04-17       Impact factor: 10.122

5.  Paradox of using intensive lowering of blood glucose in diabetics and strategies to overcome it and decrease cardiovascular risks.

Authors:  Xian-pei Heng; Liu-qing Yang; Min-ling Chen; Liang Li; Su-ping Huang; Ying Lei
Journal:  Chin J Integr Med       Date:  2015-11-03       Impact factor: 1.978

6.  Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial.

Authors:  Hertzel C Gerstein; Walter T Ambrosius; Ronald Danis; Faramarz Ismail-Beigi; William Cushman; Jorge Calles; Maryann Banerji; Ulrich Schubart; Emily Y Chew
Journal:  Diabetes Care       Date:  2012-12-13       Impact factor: 19.112

7.  Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study.

Authors:  Anne Q Reuwer; Brigitte M Sondermeijer; Suzanne Battjes; Rogier van Zijderveld; Danka J F Stuijver; Peter H Bisschop; Marcel Th B Twickler; Joost C M Meijers; Reinier O Schlingemann; Erik S Stroes
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

8.  Diabetic retinopathy and inflammation: novel therapeutic targets.

Authors:  Sampathkumar Rangasamy; Paul G McGuire; Arup Das
Journal:  Middle East Afr J Ophthalmol       Date:  2012-01

9.  Renal function but not asymmetric dimethylarginine is independently associated with retinopathy in type 2 diabetes.

Authors:  Katarzyna Krzyzanowska; Friedrich Mittermayer; Gerit H Schernthaner; Simon Brunner; Johanna M Brix; Stefan Aschauer; Florian Höllerl; Michael Wolzt; Guntram Schernthaner
Journal:  Cardiol Res Pract       Date:  2011-05-09       Impact factor: 1.866

10.  High prevalence of lower extremity peripheral artery disease in type 2 diabetes patients with proliferative diabetic retinopathy.

Authors:  Yi-Wen Chen; Ying-Ying Wang; Dong Zhao; Cai-Guo Yu; Zhong Xin; Xi Cao; Jing Shi; Guang-Ran Yang; Ming-Xia Yuan; Jin-Kui Yang
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.